An attempt to improve diet quality in youth with type 1 yields less than promising results.Read More »
While detection of type 2 diabetes for specific subgroups in the population has slightly increased, overall detection rates remain low among US adults.Read More »
When added to statin therapy in patients with diabetes, ezetimibe provides greater cardiovascular protection than what is seen in individuals without diabetes.Read More »
Long-term impact of intrauterine exposure to medication on the offspring remains unclear.Read More »
A patient that you haven’t seen for several years comes to your clinic for a wellness check-up. Since her last visit, she has gained about 15 pounds (5’6”, BMI 27 kg/m2). Her stage 1 hypertension is controlled with hydrochlorothiazide. As you discuss her weight gain, you learn that she doesn’t get more than 30 minutes a week of physical activity. You decide it would be best to check her A1C. Which of the following information from her history leads you to screen her for type 2 diabetes? A. Her youngest child weighed 8.5 pounds at birth. B. Two of her cousins have type 2 diabetes. C. She just celebrated her 41st birthday. D. She has a history of hypertension. Follow the link for the answer.Read More »
The American College of Physicians (ACP) said doctors can tell patients to aim for a glycosylated hemoglobin, or HbA1C, level between 7 percent and 8 percent, rather than the traditional 6.5 percent to 7 percent. Plus, clinicians should consider deintensifying pharmacologic therapy in patients with type 2 diabetes who achieve HbA1c levels less than 6.5%. (See article 2)
Do you agree A1c should be between 7% and 8%?
Follow the link to see what your colleagues think.
Dr. Jaime Uribarri is a physician and clinical investigator. He was born in Chile and received his medical degree from the University of Chile School of Medicine. He did all his postgraduate training in the United States. He has been in The Icahn School of Medicine at Mount Sinai, NYC, since 1990, where he is currently Professor of Medicine and Director of the Renal Clinic and the Home Dialysis Program at the Mount Sinai Hospital.Read More »
In this exclusive interview transcript, Dr. Jamie Uribarri discusses his research into Advanced Glycation Endproducts (AGEs) in food, the role they play in overall health, and how to achieve lower AGE diets through food choices and cooking techniques.Read More »
In this Exclusive Interview, Dr. Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about his research into AGEs (Advanced Glycation Endproducts) in food, how AGEs affect health and contribute to diseases like diabetes, and how people can lower AGEs in their diets through food choices and cooking techniques.Read More »
In part 1 of this Exclusive Interview, Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the compounds called Advanced Glycation Endproducts (AGE) in food, and the benefits of a low AGE diet.Read More »